CDTX PDUFA Stock Hot Trade Catalyst

Cidara Therapeutics (CDTX) has an upcoming catalyst for its antifungal drug rezafungin on March 22nd, 2023. In this video I share some of the favorable risk to reward reasons for this trade and how it can impact shareholder value and on a clinical landscape.

0:00 March 22nd, 2023 CDTX Catalyst
0:40 Rezafungin Background
2:27 Rezafungin has QIDP designation and benefits
4:55 A big approval for investors and patients
5:14 Adcom voted 14 to 1 in favor of Rezafungin
7:38 The potential to make money on this trade
8:46 What else does CDTX bring to the table
9:20 The Stock Chart, Stock Offering, and My Plan

Visit at: http://www.thetradestudy.com

SUBSCRIBE & LIKE for more videos and content. COMMENT any questions or suggestions. Thank you.

Follow at:

Instagram: http://www.instagram.com/thetradestudy
TikTok: https://vm.tiktok.com/ZMeUg68Bg
Facebook: http://www.facebook.com/thetradestudy
Twitter: http://www.twitter.com/thetradestudy

DISCLAIMER: These videos are for educational purposes only. Nothing in this video is financial advise or a recommendation to buy or sell any security or investment. Consult with a financial advisor before making any financial decisions.

Видео CDTX PDUFA Stock Hot Trade Catalyst канала The Trade Study